An interesting study showed that knocking down NRF2 in pregnancy-associated hypertension (PAH) mice (NRF2−/− PAH mice), a mouse model of PE, improved maternal and fetal survival, ameliorated intra-uterine growth retardation and increased oxidative DNA damage. This evidence concerns the gene NFE2L2 and preeclampsia.